Viruses from the Family Flaviviridae, including West Nile Virus, Dengue Virus and Hepatitis C Virus (HCV), are significant causes of morbidity and mortality, yet have few to no treatment options. Deoxyribonucleoside analogs form an important part of antiviral therapy for human immunodeficiency virus (HIV), but ribonucleoside analogs have been relatively unstudied for their potential to affect HCV or RNA viruses in general. We have determined conditions in which thiopurine nucleoside analogs inhibit a model Flaviviridae, Bovine Viral Diarrhea Virus (BVDV), in cell culture without cytotoxicity. Ribavirin, another purine analog, increases the efficacy of interferon treatment. Multiple mechanisms have been proposed for how ribavirin may act, but it remains unclear which mechanism(s) predominant. HCV positive transplant patients are often exposed to long-term immunosuppressive agents including thiopurines that also alter purine metabolism. Since these drugs share some, but not all of the mechanistic options for ribavirin, we will compare the effect of each on viral replication. The goal of this proposal is to extend these findings to HCV and determine the mechanism of action. Thiopurines will be tested for antiviral effect on the HCV replicon, and if they exert selective pressure on viral polymerases. Thiopurines will be tested for recognition, and utilization by the HCV and BVDV polymerase, which will aid us in designing more potent nucleosides. Finally we will further define the mechanism of this inhibition by looking at the size of purine pools and the effect of altering thiopurine metabolism on thiopurine's antiviral capacity. This proposal will determine the relative direct and indirect effect of thiopurines on RNA viral replication and the implications of that effect for the treatment of HCV patients with related purines such as ribavirin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08AI055750-01
Application #
6672810
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Koshy, Rajen
Project Start
2003-07-01
Project End
2006-04-30
Budget Start
2003-07-01
Budget End
2004-04-30
Support Year
1
Fiscal Year
2003
Total Cost
$129,319
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Ansari, Israr-Ul H; Allen, Todd; Berical, Andrew et al. (2013) Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility. Virology 436:268-73
Fernandes, Fiona; Poole, Daniel S; Hoover, Spencer et al. (2007) Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B. Hepatology 46:1026-33
Slattery, Wendolyn R; Juckett, Mark; Agger, William A et al. (2005) Milkers' nodules complicated by erythema multiforme and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation for multiple myeloma. Clin Infect Dis 40:e63-6